Basic Information
Seroquel XR Tablet 200mg
TABLET, EXTENDED RELEASE
Regulatory Information
SIN13503P
July 29, 2008
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XN05AH04
Company Information
LUYE PHARMA (SINGAPORE) PTE. LTD.
LUYE PHARMA (SINGAPORE) PTE. LTD.
Active Ingredients
Strength: 200 mg
Detailed Information
Contraindications
**Contraindications** SEROQUEL XR is contraindicated in patients who are hypersensitive to any component of this product.
Indication Information
**Therapeutic indications** SEROQUEL XR is indicated for the treatment of schizophrenia. SEROQUEL XR is effective in preventing relapse in stable schizophrenic patients who have been maintained on SEROQUEL XR. SEROQUEL XR is indicated for bipolar disorder: - manic episodes associated with bipolar I disorder - depressive episodes associated with bipolar disorder - preventing recurrence in maintenance treatment of bipolar disorder (manic, mixed or depressive episode) as monotherapy or in combination with lithium or valproate. SEROQUEL XR is indicated for use as add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of SEROQUEL XR.